These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 8565027)
1. Lack of hypothalamic-pituitary-adrenal axis suppression with once-daily or twice-daily beclomethasone dipropionate aqueous nasal spray administered to patients with allergic rhinitis. Brannan MD; Herron JM; Reidenberg P; Affrime MB Clin Ther; 1995; 17(4):637-47. PubMed ID: 8565027 [TBL] [Abstract][Full Text] [Related]
2. Double-strength beclomethasone dipropionate (84 micrograms/spray) aqueous nasal spray in the treatment of seasonal allergic rhinitis. Prenner BM; Chervinsky P; Hampel FC; Howland WC; Lawrence M; Meltzer EO; Munk ZM; Ratner PH; Seltzer JM; Settipane GA; Lorber RR; Harrison JE J Allergy Clin Immunol; 1996 Aug; 98(2):302-8. PubMed ID: 8757207 [TBL] [Abstract][Full Text] [Related]
3. Effect of fluticasone propionate aqueous nasal spray versus oral prednisone on the hypothalamic-pituitary-adrenal axis. Vargas R; Dockhorn RJ; Findlay SR; Korenblat PE; Field EA; Kral KM J Allergy Clin Immunol; 1998 Aug; 102(2):191-7. PubMed ID: 9723660 [TBL] [Abstract][Full Text] [Related]
4. No hypothalamic-pituitary-adrenal function effect with beclomethasone dipropionate nasal aerosol, based on 24-hour serum cortisol in pediatric allergic rhinitis. Hampel FC; Nayak NA; Segall N; Small CJ; Li J; Tantry SK Ann Allergy Asthma Immunol; 2015 Aug; 115(2):137-42. PubMed ID: 26250771 [TBL] [Abstract][Full Text] [Related]
5. A systemic bioactivity comparison of double-strength and regular-strength beclomethasone dipropionate MDI formulations. Brannan MD; Herron JM; Reidenberg P; Affrime MB Ann Allergy Asthma Immunol; 1998 Jan; 80(1):39-44. PubMed ID: 9475565 [TBL] [Abstract][Full Text] [Related]
6. A comparison of once-daily triamcinolone acetonide aqueous and twice-daily beclomethasone dipropionate aqueous nasal sprays in the treatment of seasonal allergic rhinitis. Lumry W; Hampel F; LaForce C; Kiechel F; el-Akkad T; Murray JJ Allergy Asthma Proc; 2003; 24(3):203-10. PubMed ID: 12866325 [TBL] [Abstract][Full Text] [Related]
7. Beclomethasone dipropionate aqueous nasal spray for seasonal allergic rhinitis in children. Kobayashi RH; Tinkelman DG; Reese ME; Sykes RS; Pakes GE Ann Allergy; 1989 Mar; 62(3):205-8. PubMed ID: 2646995 [TBL] [Abstract][Full Text] [Related]
8. Safety and tolerability of once-daily mometasone furoate aqueous nasal spray in children. Brannan MD; Herron JM; Affrime MB Clin Ther; 1997; 19(6):1330-9. PubMed ID: 9444443 [TBL] [Abstract][Full Text] [Related]
9. Clinical review of once-daily beclomethasone dipropionate for seasonal allergic rhinitis. Chervinsky P Clin Ther; 1996; 18(5):790-6; discussion 789. PubMed ID: 8930423 [TBL] [Abstract][Full Text] [Related]
10. Effect of budesonide aqueous nasal spray on hypothalamic-pituitary-adrenal axis function in children with allergic rhinitis. Kim KT; Rabinovitch N; Uryniak T; Simpson B; O'Dowd L; Casty F Ann Allergy Asthma Immunol; 2004 Jul; 93(1):61-7. PubMed ID: 15281473 [TBL] [Abstract][Full Text] [Related]
11. Once-daily treatment with beclomethasone dipropionate nasal aerosol does not affect hypothalamic-pituitary-adrenal axis function. Ratner PH; Miller SD; Hampel FC; Melchior A; Dunbar SA; Tantry SK Ann Allergy Asthma Immunol; 2012 Nov; 109(5):336-41. PubMed ID: 23062389 [TBL] [Abstract][Full Text] [Related]
12. Detection of growth suppression in children during treatment with intranasal beclomethasone dipropionate. Skoner DP; Rachelefsky GS; Meltzer EO; Chervinsky P; Morris RM; Seltzer JM; Storms WW; Wood RA Pediatrics; 2000 Feb; 105(2):E23. PubMed ID: 10654983 [TBL] [Abstract][Full Text] [Related]